Free Trial

NovoCure (NVCR) SEC Filings & 10K Form

NovoCure logo
$30.80 +0.40 (+1.32%)
(As of 12/20/2024 05:51 PM ET)

Recent NovoCure SEC Filings

DateFilerForm TypeView
12/02/2024
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:27 PM
NovoCure (Issuer)
Paravasthu Mukund (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
6:02 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
6:00 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/15/2024
3:05 PM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
5:21 PM
NovoCure (Issuer)
Paravasthu Mukund (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2024
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:16 PM
NovoCure (Issuer)
Puri Michal Nath (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:17 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:19 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:19 PM
Danziger Asaf (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
7:19 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:20 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:21 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:22 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:24 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:25 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:16 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:17 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:18 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
6:01 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2024
6:05 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/10/2024
12:14 PM
NovoCure (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
07/08/2024
3:32 PM
BlackRock Inc. (Filed by)
NovoCure (Subject)
Form SC 13G/A
06/06/2024
5:37 PM
NovoCure (Issuer)
Ocean Allyson J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
5:13 PM
Madden Martin J. (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:55 PM
Hung David (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:42 PM
LEUNG GABRIEL (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:42 PM
NovoCure (Issuer)
Scannell Timothy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:43 PM
NovoCure (Issuer)
VERNON W ANTHONY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:43 PM
NovoCure (Issuer)
Stafford Kristin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:09 PM
HILLEMAN JERYL L (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
7:01 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
6:01 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
6:01 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/27/2024
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
5:39 PM
NovoCure (Subject)
Shah Pritesh (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
5:17 PM
GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
3:43 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:33 PM
Giladi Moshe (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:33 PM
Leupin Nicolas (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad)

You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.

Click Here to get the full details about Crypto’s Hidden Gem
02/29/2024
3:35 PM
NovoCure (Issuer)
Weinberg Uri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
6:11 AM
NovoCure (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/22/2024
6:05 AM
NovoCure (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2024
6:06 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
8:28 AM
FMR LLC (Filed by)
NovoCure (Subject)
Form SC 13G/A
01/18/2024
6:01 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2024
3:57 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/11/2024
4:15 PM
Leupin Nicolas (Reporting)
NovoCure (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/09/2024
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
6:10 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
3:10 PM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NVCR) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners